共 50 条
- [32] Vedolizumab Decreases Utilization of Healthcare Resources in Biologic-naive Inflammatory Bowel Disease (IBD) Patients AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S334 - S335
- [38] Response and Healthcare Resource Utilization in Inflammatory Bowel Disease Patients Treated With Either Infliximab or Vedolizumab AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S485 - S485
- [40] Malnutrition and quality of life among adult inflammatory bowel disease patients JGH OPEN, 2020, 4 (03): : 454 - 460